Rayaldee - what we know - on June 5th the company increased their sales reps from 35 to 75. On June 22nd KGIDO issued a clinical practice update sighting current practices are not only INEFFECTIVE but potentially HARMFUL. Rayaldee is obviously sighted as the new novel go to therapy which works as advertised. It also goes on to mention a safety profile similar to placebo. The entire update reads like a marketing supplement from the company. The company has had basically three full months going around to Dr's with this update in hand, you have to think they are making progress. I personally don't know how a Dr can read this clinical update and not want to get their patients on Rayaldee or at the very least learn about the drug.
I've always thought this drug had blockbuster potential, nothing has changed that opinion. I also believe that this drug can be a safe and effective combo drug in folks with RA and MS. Something like 80 + % of newly diagnosed MS patients are vitamin D deficient. BTW, Claros will have a test to check that.
VASR's stock plunged today on news their pediatric HGH failed to show any improvement over it's competitor PFE. ASND stock went up 25% based on they are completing enrollment in their phase three study of the same drug in the fourth quarter with results in fourth quarter of 2018. OPKO is on the same schedule as ASND and has a better delivery device. OPKO is getting ready to submit their new BLA on the adult HGH. If the BLA is accepted and I think it will be then look for a big pop in OPKO share price. PFE already dominates the pediatric HGH market and approval of the adult HGH with it's delivery device will allow PFE and OPKO to get their once weekly pediatric HGH to market much quicker than ASND and continue to dominate the HGH market.
Big week coming up for Opko! How management handles these investor presentations will be key! They botched the Wells Fargo one, and Frost was a total mess on Mad Money, and sounded like a cheerleading bafoon! I'm hoping against all odds that this management gets a kick in the gut and steps it up this week.
Cantor Fitzgerald OPK conference 25 September, 2017: Cantor has a $25 price target on OPK. JP Morgan's Eric Joseph has a $7 price target. LOL LOL
This guy Joseph has a PhD-- now you can see what a PhD is worth-- effing nothing.
Nice write-up about OPKO's prospects regarding pediatric HGH in light of VSAR's debacle. Check out www.benzinga.com
Charts and technicals clearly show we are within days of an upside breakout. Accumulation level has hit a new record. The upcoming run will beat the last run from $6.00 to $19.00. This time it will not retrace because fundamentals will support the valuation.
Time for new leadership before this pos stock goes back below 6 and then to 4
I have posted here in the past. And I will repeat- I have been at this game a long time.. In terms of OPK I have a ton of shares and am losing quite a bunch on paper. With that said, I have not sold one share. I went thru almost the same deal with IVX before TEVA bought it out. IVX was dragged thru the mud, bashed by everyone including the Analysts. It was a failing entity, going bankrupt, etc. Then it slowly turned and the result for the longs was very rewarding.. BUT it took time. In terms of OPK, I am the first to admit that I loaded up at the wrong intervals. I never expected to see it anywhere near where it is today. So I readily admit its been an awful investment SO FAR. But what most dont understand is that it takes a great deal of time, expertise, patience, and vision to build a successful and profitable entity. Especially in the biotech health care world that is extremely regulated and risky due to the trial and errors. Dr. Frost expects X amount of things to fail - But he has an phenomenal track record of carefully building successful businesses. No hype intended by the way.. It doesn't matter to me at all if people sell of short OPK.. Im just going to do the exact thing I did with IVX. Hold thru all the storms. D
@r still crying little man??????
As I wrote in here before - Dr. Frost is not going anywhere. He will stay at Opko until very good results are published and/or Opko will be bought out (by Fizer?) and the shorts are fried - "very well done"!!! Dr. Frost will NOT leave Opko and its shareholders in the sad situation that the company's shares are trading at.
Dr. Frost will probably also outlive shady, angry and cursing characters like R and Gdog. These two, with their angry gens - I believe that Dr. Frost will outlive them both !
And yesterday and today, when the stock is going higher on a nice volume, this fact should make the shorts worried. Very worried.
Frost is the real thing.Some of the younger investors might not understand his motivation.He is going out a winner.Doubt him at your peril.
Hmmmmmm. A downgrade by JP SMORGAN recently now a nice move up the last few days on good volume. Could it be the classic "downgrade" to get people to sell right before good news???? seems like it
Where are Jim and Stuart now? Margin call...can't wait. I usually don't want anybody to lose money, but these two pigs deserve it so much!!!
OPK is taking a breather. So everyone CHILL-OUT. Does a horse run the next day after winning the British Open ? Heck no : the trainer rests him. OPK won't go to $20 over-night. Patience,. By Dec. you will be singing Dixie.
@Gdog glad you made money by shorting it. now act wise and go long if interested in making more. you better cover buddy
Weekend pumpathon a total failure. The pig dung will go right back down next week and there isn't anything any pumptard can say to stop it. The pump and dump will end early Monday morning and then look out below! all you new bag holders will learn the hard way, as usual.
$6.66 Oh yeah, my favorite number.
This is the run, no downgrades to stop us this time. 6 dollars will soon be a thing of the past. Once the shorttards start covering it will be like a stampede.
Epic squeeze is in motion!!
The picture seems quite simple:
1. someone is playing short accumulating shares - JPM etc 2. Old dude keeps accumulating while enjoying short positions - he is no fool 3. Stock is forced to be at a certain level. Why? simple to figure out....take over or buyout 4. Strong pipeline line ready to gain huge market share
So invest based on the facts NOT how you feel about your short term gain or loss